Business Context and Reporting Period
This Form 8-K Current Report was filed by Intelligent Bio Solutions Inc. on July 3, 2025, covering events that occurred on June 30, 2025. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, NY. The filing primarily addresses amendments to executive employment agreements and salary adjustments.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation terms.
Material Changes
On June 30, 2025, the Board of Directors approved amendments to the employment agreements of the President and CEO, Harry Simeondis, and the CFO, Spiro Sakiris. Key changes include:
- Salary Increases:
- Mr. Simeondis: Increased from AUD$560,000 to AUD$580,000 annually.
- Mr. Sakiris: Increased from AUD$410,000 to AUD$430,000 annually.
- Non-Compete Provisions: Revised to a tiered structure ranging from 24 months down to 1 month based on enforceability, with expanded scope prohibiting direct or indirect involvement with competing entities.
- Severance Enhancements (Termination Without Cause):
- 100% of potential bonus payable regardless of performance.
- Immediate full vesting of all outstanding equity awards.
- Change in Control (CIC) Severance: In the event of a CIC and termination without cause, executives receive:
- Two times annual base salary.
- 100% of potential bonus.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, operational outlook, or general risk factors. However, it defines a "Change in Control" for severance purposes, which includes:
- Acquisition of more than 20% of voting stock by a person or group.
- Certain mergers or consolidations resulting in a change in voting power.
- Sale or disposition of all or substantially all assets.
- Changes in the majority composition of the Board.
Note: Stock repurchases by the Company are explicitly excluded from the Change in Control definition.
Investor Verification Checklist
- Verify the exact terms of the "tiered structure" for non-compete periods in the full text of Exhibits 10.1 and 10.2.
- Confirm the currency conversion impact of the AUD salary increases on the Company's USD financial statements.
- Review the specific definitions of "Change in Control" and "termination without cause" in the attached exhibits to understand potential future cash outflows.
- Check for any related proxy statements or shareholder approvals required for these compensation changes, given the Company's status as an emerging growth company.